tirzepatide summit In the trial, researchers examined cardiovascular outcomes of treatment with in patients with heart failure with preserved ejection fraction and obesity. Full trial results and Plain Language Summary: https://nej.md/4hRGaTY Medthreads Tirzepatide for HFPEF and Obesity

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have transformed the weight loss and diabetes management landscape

New constructs reported in this Article are available from Addgene: H2BHTemiRFP703 (183985), HTmGold (183986), calnexinHTmGold (183987), H2BHTmGold (183988) and calnexinHT8mGold (183989)

The STEP trials, which evaluated once-weekly semaglutide for chronic weight management, showed that patients on 2.4 mg experienced average weight loss of 15% body weight over 68 weeks compared to 2.6% for placebo

Upon successful completion of this Phase 1 project we intend to further develop our concept/prototype assay, complete the device design and integrate the finished test with a reader instrument through a Phase 2 proposal

Challenges associated with insulin therapy in type 2 diabetes mellitus